Table 2.

Markers of Pulmonary Morbidity after Discharge from the NICU

	INO (%)	Placebo (%)	OR* (95%CI)	NNT** (95% CI)
Wheezing or whistling in the chest	49.6	56.4	0.70 (0.48–1.03)	---
Bronchodilator Use	40.1	54.1	0.53 (0.36–0.78)	6.3 (4.0–15.6)
Inhaled Steroid Use	19.8	32.4	0.50 (0.32–0.77)	7.5 (4.6, 19.6)
Systemic Steroid Use	11.0	17.7	0.56 (0.32–0.97)	14.1 (7.3, 250.0)
Diuretic Use	18.6	28.4	0.54 (0.34–0.85)	9.0 (5.2–33.3)
Any Home O2 Use	38.4	49.5	0.65 (0.44–0.95)	9.4 (5.0, 76.9)
Persistent O2 Use at Time of Follow-Up	3.0	9.4	0.30 (0.13–0.73)	15.9 (9.4–52.6)
Any Hospitalization	46.5	50.4	0.83 (0.57–1.21)	---
Respiratory Hospitalization	22.6	21.9	1.03 (0.65–1.62)	---

^*Odds Ratio

^**Number needed to treat were calculated by GEE. NNT represents the number of patients that would need to be treated with a therapy in order to improve one patient’s outcome. Respiratory hospitalizations included admissions for wheezing and/or respiratory infection.